Novartis to Expand Nuclear Medicine Factory near Indy Airport

A Swiss-based drugmaker plans to double the size of its Indianapolis manufacturing plant, which produces nuclear medicine imaging and therapy products for cancer, in a move that would create 55 jobs with an average wage of $95,000.

Novartis Manufacturing LLC told a committee of the City-County Council on Monday evening that it plans to spend up to $125 million to construct and equip a 79,000-square-foot-building for radiopharmaceutical manufacturing  and distribution on the city’s west side.

The move is a sudden ramp-up for the company. Just four months ago, Novartis got permission from the U.S. Food and Drug Administration to begin commercial manufacturing at the site of a drug called Pluvicto, which is used to treat advanced-stage prostate cancer. The plant, which broke ground in 2020, went online shortly afterward.

Full Story via Indianapolis Business Journal